Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 8.60
+0.06 (0.64%)
Oct 30, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -209.94 | -245.51 | -556.43 | -300.56 | -461.58 | -162.45 |
Depreciation & Amortization | 31.13 | 29.64 | 33.18 | 31.44 | 18.14 | 15.47 |
Other Amortization | 0.41 | 0.41 | 0.58 | 0.73 | - | - |
Loss (Gain) From Sale of Assets | -6.88 | -2.65 | 7.57 | -1.02 | - | - |
Loss (Gain) From Sale of Investments | 8.09 | 6.01 | -9.16 | -15.93 | - | - |
Stock-Based Compensation | - | - | 402.9 | 72.27 | - | - |
Other Operating Activities | 28.36 | 15.04 | 2.14 | 3.45 | 32.01 | -60.66 |
Change in Accounts Receivable | -43.84 | -16.36 | -0.19 | - | - | - |
Change in Inventory | -36.36 | -36.99 | 3.35 | -12.87 | - | - |
Change in Accounts Payable | 62.41 | 14.69 | 29.67 | 29.48 | - | - |
Change in Unearned Revenue | -17.2 | -4.31 | -3.55 | - | - | - |
Change in Other Net Operating Assets | -5.83 | 30.07 | -37.16 | 77.07 | - | - |
Operating Cash Flow | -189.65 | -209.96 | -127.09 | -115.95 | -411.43 | -207.65 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -0.79 | -0.57 | -0.51 | -1.74 | -75.99 | -57.26 |
Sale of Property, Plant & Equipment | 39.65 | 39.64 | - | 0.01 | 0.02 | 180.46 |
Cash Acquisitions | - | - | - | - | -131 | - |
Sale (Purchase) of Intangibles | -46.49 | -39.74 | -73.05 | -144.61 | - | - |
Investment in Securities | 101.77 | 112.43 | 205.49 | 191.08 | 250.61 | -292.93 |
Other Investing Activities | - | - | - | - | 5.14 | -5 |
Investing Cash Flow | 94.14 | 111.75 | 131.93 | 44.73 | 48.77 | -174.73 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Issued | - | 10 | - | - | 200 | - |
Long-Term Debt Repaid | - | -10.88 | -5.26 | -7.58 | -200 | -8 |
Lease Payments | -0.88 | -0.88 | -5.26 | -7.58 | - | - |
Net Debt Issued (Repaid) | -0.88 | -0.88 | -5.26 | -7.58 | - | -8 |
Issuance of Common Stock | 659.05 | 659.05 | - | - | 866.21 | 925.93 |
Common Dividends Paid | - | - | - | - | -0.45 | -0.19 |
Other Financing Activities | -38.17 | -35.72 | -7.16 | -2.33 | -8.08 | -3.23 |
Financing Cash Flow | 620 | 622.45 | -12.43 | -9.9 | 857.69 | 914.51 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | -24.58 | -7.26 | -0.05 | -0.1 | -0.01 | 0.02 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - |
Net Cash Flow | 499.91 | 516.98 | -7.64 | -81.22 | 495.01 | 532.16 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -190.44 | -210.54 | -127.6 | -117.69 | -487.42 | -264.9 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -184.32% | -406.66% | -424.00% | -405831.03% | - | - |
Free Cash Flow Per Share | -0.38 | -0.45 | -0.28 | -0.26 | -1.24 | - |
Levered Free Cash Flow | -220.51 | -170.67 | 20.65 | - | -336.77 | -171.5 |
Unlevered Free Cash Flow | -220.44 | -170.6 | 20.84 | - | -336.08 | -171.26 |
Free Cash Flow After Leases | -191.32 | -211.42 | -132.86 | -125.27 | -487.42 | -264.9 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Interest Paid | 0.08 | 0.08 | - | - | - | - |
Cash Income Tax Paid | 0.01 | 0.01 | 0.01 | 0.01 | 7.87 | 2.97 |
Change in Working Capital | -40.82 | -12.9 | -7.87 | 93.68 | - | - |